Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Change in Taxes (2025)

Keros Therapeutics' Change in Taxes history spans 1 years, with the latest figure at -$1.9 million for Q4 2025.

  • For Q4 2025, Change in Taxes changed N/A year-over-year to -$1.9 million; the TTM value through Dec 2025 reached $2.2 million, changed N/A, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
  • Change in Taxes reached -$1.9 million in Q4 2025 per KROS's latest filing, up from -$2.2 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $10.0 million in Q1 2025 to a low of -$3.7 million in Q2 2025.